阻塞性睡眠呼吸中止症 - 全球臨床試驗評論 (2024)

本報告研究了阻塞性睡眠呼吸中止症的臨床試驗，並提供了每個國家臨床試驗數量和平均入組人數的數據，以及主要公司的評論和相關臨床試驗的清單。

目錄

表格列表

圖表列表

• 報告指南
• GlobalData 臨床試驗報告覆蓋範圍
• 按地區劃分的臨床試驗
• 各國臨床試驗及平均入組人數
• 亞太地區臨床試驗貢獻最大的 5 個國家
• 對歐洲臨床試驗貢獻最大的 5 個國家
• 對北美臨床試驗貢獻最大的國家
• 對中東和非洲臨床試驗貢獻最大的 5 個國家
• 拉丁美洲臨床試驗貢獻最多的國家
• G7 臨床試驗：呼吸臨床試驗中阻塞性睡眠呼吸中止症的百分比
• G7 國家各階段臨床試驗狀況
• G7 國家臨床試驗情況（依試驗狀態）
• E7 臨床試驗：呼吸臨床試驗中阻塞性睡眠呼吸中止症的百分比
• E7 國家依階段進行的臨床試驗
• E7 國家/地區臨床試驗（依試驗狀態）
• 臨床試驗：依階段
• 依階段進行的試驗
• 臨床試驗：依試驗狀態
• 臨床試驗：依終點狀態
• 在一段時間內招募受試者
• 以申辦單位類型劃分的臨床試驗
• 著名贊助商
• 參與阻塞性睡眠呼吸中止症治療臨床試驗的主要公司
• 著名藥物
• 阻塞性睡眠呼吸中止症的最新臨床試驗新聞
• 2024 年 11 月 8 日：Axsome Therapeutics 將在 2024 年 NEI 大會上展示 Solriamfetol 數據
• 2024 年 10 月 29 日：Axsome Therapeutics 將在 2024 年心理學大會上展示 Solriamfetol 數據
• 臨床試驗概況快照

附錄

GlobalData's clinical trial report, "Obstructive Sleep Apnea - Global Clinical Trials Review, 2024" provides an overview of Obstructive Sleep Apnea Clinical trials scenario. This report provides top line data relating to the clinical trials on Obstructive Sleep Apnea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level
• Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

• Report Guidance
• GlobalData Clinical Trials Report Coverage
• Clinical Trials by Region
• Clinical Trials and Average Enrollment by Country
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific
• Top Five Countries Contributing to Clinical Trials in Europe
• Top Countries Contributing to Clinical Trials in North America
• Top Five Countries Contributing to Clinical Trials in Middle East and Africa
• Top Countries Contributing to Clinical Trials in Central and South America
• Clinical Trials by G7 Countries: Proportion of Obstructive Sleep Apnea to Respiratory Clinical Trials
• Clinical Trials by Phase in G7 Countries
• Clinical Trials in G7 Countries by Trial Status
• Clinical Trials by E7 Countries: Proportion of Obstructive Sleep Apnea to Respiratory Clinical Trials
• Clinical Trials by Phase in E7 Countries
• Clinical Trials in E7 Countries by Trial Status
• Clinical Trials by Phase
• In Progress Trials by Phase
• Clinical Trials by Trial Status
• Clinical Trials by End Point Status
• Subjects Recruited Over a Period of Time
• Clinical Trials by Sponsor Type
• Prominent Sponsors
• Top Companies Participating in Obstructive Sleep Apnea Therapeutics Clinical Trials
• Prominent Drugs
• Latest Clinical Trials News on Obstructive Sleep Apnea
• Nov 08, 2024: Axsome Therapeutics Presents Data On Solriamfetol at NEI Congress 2024
• Oct 29, 2024: Axsome Therapeutics Presents Data from Solriamfetol at Psych Congress 2024
• Clinical Trial Profile Snapshots

Appendix

• Abbreviations
• Definitions
• Research Methodology
• Secondary Research
• About GlobalData
• Contact Us
• Source

List of Tables

• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials by Region, 2024*
• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2024*
• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Europe, Top Five Countries, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, North America, Top Countries, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Central and South America, Top Countries, 2024*
• Proportion of Obstructive Sleep Apnea to Respiratory Clinical Trials, G7 Countries (%), 2024*
• Obstructive Sleep Apnea Therapeutics, G7 Countries, Clinical Trials by Phase, 2024*
• Obstructive Sleep Apnea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2024*
• Proportion of Obstructive Sleep Apnea to Respiratory Clinical Trials, E7 Countries (%), 2024*
• Obstructive Sleep Apnea Therapeutics, E7 Countries, Clinical Trials by Phase, 2024*
• Obstructive Sleep Apnea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2024*
• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials by Phase, 2024*
• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials In Progress by Phase 2024*
• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials by Trial Status, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Global, by End Point Status, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2019-2023
• Obstructive Sleep Apnea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Global, Key Sponsors, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2024*

List of Figures

• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials by Region (%), 2024*
• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2024*
• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, North America, Top Countries (%), 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2024*
• Proportion of Obstructive Sleep Apnea to Respiratory Clinical Trials, G7 Countries (%), 2024*
• Obstructive Sleep Apnea Therapeutics, G7 Countries, Clinical Trials by Phase, 2024*
• Obstructive Sleep Apnea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2024*
• Proportion of Obstructive Sleep Apnea to Respiratory Clinical Trials, E7 Countries (%), 2024*
• Obstructive Sleep Apnea Therapeutics, E7 Countries, Clinical Trials by Phase, 2024*
• Obstructive Sleep Apnea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2024*
• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials by Phase (%), 2024*
• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials In Progress by Phase, 2024*
• Obstructive Sleep Apnea Therapeutics, Global, Clinical Trials by Trial Status, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Global, by End Point Status, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2019-2023
• Obstructive Sleep Apnea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Global, Key Sponsors, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2024*
• Obstructive Sleep Apnea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2024*
• GlobalData Methodology